Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on L 1. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN112480015B details a Pd-catalyzed one-pot method for 2-trifluoromethyl quinazolinones, offering high yields and broad substrate scope for API manufacturing.
Patent CN111018800B reveals a mild copper-catalyzed route for N2-aryl-1,2,4-triazine derivatives, offering cost reduction in API manufacturing and scalable production.
Patent CN116813544B reveals catalyst-free heating method. Enhances supply chain reliability and cost efficiency for pharmaceutical intermediates manufacturing globally with green chemistry.
Patent CN116253692A reveals a metal-free route for trifluoromethyl 1,2,4-triazines. This method offers significant cost reduction in API manufacturing and enhanced supply chain reliability.
Novel quinoline-substituted ligand enables high ee asymmetric trifluoromethylation. Cost-effective synthesis for pharmaceutical intermediate manufacturing supply chain.
Novel Pd-catalyzed carbonylation patent CN115286628B enables efficient synthesis. Offers supply chain reliability and cost reduction for pharmaceutical intermediate manufacturing.
Patent CN102256981A details a novel route for Anagrelide avoiding toxic nitriles and tin waste, offering cost reduction in pharmaceutical manufacturing and high-purity intermediates.
Novel Pd-catalyzed carbonylation method for quinazolinones using solid CO surrogate. Enhances safety and yield for API intermediates.
Patent CN113105402B reveals a metal-free iodine-promoted route for 1,2,4-triazoles, offering significant cost reduction and scalable manufacturing for pharmaceutical intermediates.
Novel synthesis of axial chiral cyclopentenyl indole-naphthyl compounds via chiral phosphoric acid. High enantioselectivity and cytotoxic activity for pharmaceutical applications.
Novel palladium-catalyzed synthesis offers high efficiency and substrate compatibility for pharmaceutical intermediate manufacturing supply chains.
Patent CN117417339A details Rhodium-catalyzed synthesis offering high purity and scalable production for global pharmaceutical supply chains.
Patent CN112538059B enables high-purity oxazole-4-carboxylic ester manufacturing with atom economy. Reduces waste and cost for pharmaceutical intermediate supply chains globally.
Patent CN108976198B details a metal-free iodine-catalyzed route for 3-(4-pyridine) indoles. Offers cost reduction in pharma intermediate manufacturing with high purity.
Discover the novel Cu-catalyzed synthesis of trifluoromethyl-substituted dihydrofuran amines. A robust method for high-purity pharmaceutical intermediates with scalable potential.
Patent CN113105402A details a metal-free iodine-catalyzed route for 3,4,5-trisubstituted 1,2,4-triazoles, offering significant cost reduction and scalability for pharmaceutical manufacturing.
Patent CN112480015B details a safe one-pot synthesis of 2-trifluoromethyl quinazolinones using nitro compounds, offering significant cost reduction and supply chain reliability for API manufacturing.
Patent CN113045489B details a novel Pd-catalyzed aminocarbonylation route for 3-arylquinolin-2(1H)ones, offering significant cost reduction in API manufacturing and enhanced supply chain reliability.
Novel CuCl-catalyzed route offers cost reduction and scalable production for high-purity pharmaceutical intermediates without anhydrous conditions.
Novel Pd-catalyzed one-pot method for trifluoromethyl chromone quinoline. Enhances supply chain reliability and cost reduction in pharmaceutical intermediate manufacturing.